Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
0.7700
+0.0473 (6.54%)
At close: Dec 10, 2025, 4:00 PM EST
0.7800
+0.0100 (1.30%)
After-hours: Dec 10, 2025, 5:28 PM EST
Rallybio Market Cap
Rallybio has a market cap or net worth of $32.53 million as of December 10, 2025. Its market cap has decreased by -20.69% in one year.
Market Cap
32.53M
Enterprise Value
-26.01M
1-Year Change
-20.69%
Ranking
Category
Stock Price
$0.77
Market Cap Chart
Since the IPO on July 29, 2021, Rallybio's market cap has decreased from $405.60M to $32.53M, a decrease of -91.98%. That is a compound annual growth rate of -43.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 30.53M | -23.35% |
| Dec 31, 2024 | 39.83M | -55.91% |
| Dec 29, 2023 | 90.33M | -63.67% |
| Dec 30, 2022 | 248.60M | -18.90% |
| Dec 31, 2021 | 306.52M | -24.43% |
| Jul 29, 2021 | 405.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 879.46B |
| Johnson & Johnson | 481.76B |
| AbbVie | 394.11B |
| UnitedHealth Group | 293.13B |
| AstraZeneca | 280.62B |
| Novartis AG | 254.28B |
| Merck & Co. | 240.48B |
| Thermo Fisher Scientific | 211.55B |